Canada· CA-DIN-02483394
IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
A salbutamol und ipratropium bromid product containing ipratropium bromide (ipratropium bromide monohydrate) + salbutamol (salbutamol sulfate), registered in Canada by JUNO PHARMACEUTICALS CORP.. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Salbutamol und ipratropium bromid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL02 (salbutamol und ipratropium bromid), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Salbutamol und ipratropium bromid · ATC R03AL02
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE MONOHYDRATE) + SALBUTAMOL (SALBUTAMOL SULFATE)
- Manufacturer
- JUNO PHARMACEUTICALS CORP.
- Country
- Canada (CA)
- ATC code
- R03AL02
- ATC class
- Salbutamol und Ipratropium bromid
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Salbutamol und ipratropium bromid in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCombiprasal 0.5mg/2.5mg nebuliser solution 2.5ml unit dose vialsTriOn Pharma Ltd
- United StatesCombivent RespimatBoehringer Ingelheim Pharmaceuticals, Inc.
- NetherlandsCombivent Unit Dose, verneveloplossingBoehringer Ingelheim B.V.
- FinlandAtrodualOrifarm Oy
- GermanyCombiprasalPenta Arzneimittel Gmbh
- IrelandCombiprasal 0.5 mg/2.5 mg per 2.5 ml nebuliser solutionPharma Stulln GmbH
- ItalyALMEIDAISTITUTO BIOCHIMICO NAZIONALE SAVIO S.R.L.
- SwedenCombivent 0,5 mg/2,5 mg Lösning för nebulisatorBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Combivent Einzeldosisbehältnissen
- Belgium · Combivent, Ipratropium Bromide/Salbutamol Neutec
- Cyprus · Berovent
- Germany · Combiprasal, Ipramol Steri-Neb
- Denmark · Combivent, Ipramol Steri-Neb
- Spain · Bivair, Bromuro De Ipratropio /Salbutamol Neutec
- Finland · Atrodual, Ipratropium Bromide/Salbutamol Neutec
- United Kingdom (Northern Ireland) · Combiprasal, Combivent Udvs
- Greece · Berovent, Demoren
- Croatia · Ipratropijev Bromid/Salbutamol Cipla, Ipsalvio
- Ireland · Combiprasal, Ipramol Steri-Neb
- Iceland · Ipratropium Bromide/Salbutamol Neutec
- Italy · Almeida, Biwind
- Luxembourg · Combivent
- Malta · Ipratropium Bromide/Salbutamol Azure
- Netherlands · Combivent Unit Dose, Ipramol Steri-Neb
- Norway · Ipratropiumbromid/Salbutamol Neutec
- Poland · Ipratropium/Salbutamol Cipla, Iprixon Neb
- Portugal · Brometo De Ipratrópio + Salbutamol, Combivent Unidose
- Romania · Ipratropiu/Salbutamol Cipla
- Sweden · Combivent, Ipratropium/Salbutamol Neutec
- Slovenia · Ipsalvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cca08974-3104-431b-aba5-3af89821f24e GET /v1/drugs/cca08974-3104-431b-aba5-3af89821f24e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02483394",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INHALATION"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R03AL02",
"schedule": [
"Prescription"
],
"drug_code": "97384",
"strengths": [
"0.5 MG",
"2.5 MG"
],
"ahfs_class": null,
"substances": [
"IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE MONOHYDRATE)",
"SALBUTAMOL (SALBUTAMOL SULFATE)"
],
"product_categorization": null
}See everything about salbutamol und ipratropium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.